These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9175142)

  • 1. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography.
    Gambhir S; Inao S; Tadokoro M; Nishino M; Ito K; Ishigaki T; Kuchiwaki H; Yoshida J
    Neurol Res; 1997 Apr; 19(2):139-44. PubMed ID: 9175142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of cerebral blood flow and MCA flow velocity measured in healthy volunteers during acetazolamide and CO2 stimulation.
    Ulrich PT; Becker T; Kempski OS
    J Neurol Sci; 1995 Apr; 129(2):120-30. PubMed ID: 7608725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide.
    Ringelstein EB; Van Eyck S; Mertens I
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):162-8. PubMed ID: 1727137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of regional vasomotor responses to acetazolamide and CO2 in rabbit cerebrum and cerebellum, measured by a hydrogen clearance method.
    Csete K; Vezekényi Z; Dóczi T; Papp JG; Bodosi M; Barzó P
    Acta Physiol Scand; 2004 Nov; 182(3):287-94. PubMed ID: 15491407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers.
    Okazawa H; Yamauchi H; Sugimoto K; Toyoda H; Kishibe Y; Takahashi M
    J Cereb Blood Flow Metab; 2001 Dec; 21(12):1472-9. PubMed ID: 11740209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.
    Nariai T; Senda M; Ishii K; Wakabayashi S; Yokota T; Toyama H; Matsushima Y; Hirakawa K
    Stroke; 1998 Jul; 29(7):1281-92. PubMed ID: 9660374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
    Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
    J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT.
    Leinsinger G; Piepgras A; Einhäupl K; Schmiedek P; Kirsch CM
    AJNR Am J Neuroradiol; 1994 Aug; 15(7):1327-32. PubMed ID: 7976945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide.
    Arigoni M; Kneifel S; Fandino J; Khan N; Burger C; Buck A
    Eur J Nucl Med; 2000 Oct; 27(10):1557-63. PubMed ID: 11083547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of the cerebrovascular responses to CO2 and Diamox in patients with unilateral occlusive cerebral arteries: a H2(15)O PET study].
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1995 Jun; 32(6):569-77. PubMed ID: 7674567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Masuda K
    Stroke; 1995 Oct; 26(10):1825-9. PubMed ID: 7570733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus.
    Müller M; Voges M; Piepgras U; Schimrigk K
    Stroke; 1995 Jan; 26(1):96-100. PubMed ID: 7839406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of carbon dioxide and acetazolamide on cerebral blood flow in occlusive cerebral vascular diseases.
    Vejjajiva A; Kashemsant U; Chipman M; Biggers WH
    J Med Assoc Thai; 1971 Feb; 54(2):91-7. PubMed ID: 5579273
    [No Abstract]   [Full Text] [Related]  

  • 17. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
    Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
    Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral perfusion reserve indexes determined by fluoromethane positron emission scanning.
    Levine RL; Sunderland JJ; Lagreze HL; Nickles RJ; Rowe BR; Turski PA
    Stroke; 1988 Jan; 19(1):19-27. PubMed ID: 3122375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis].
    Sugawara Y
    Kaku Igaku; 1995 Mar; 32(3):287-99. PubMed ID: 7739159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
    Yamauchi H; Okazawa H; Kishibe Y; Sugimoto K; Takahashi M
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.